Yes, There Are Other Advantages [Bob]

To follow up on Scott's post yesterday, the actual press release from the American College of Cardiology lists the following as the "unique advantages" of the mesenchymal stem cell (MSC) therapy as follows:

MSCs have a number of unique advantages: they can be taken from genetically distinct donors, are easy to prepare, and have a tendency to collect within injured areas

Apparently it is not worth mentioning that these are adult bone marrow stem cells and, as such, offer the additional "unique advantage" of not requiring the practice of embryo destruction to obtain them.

Meanwhile, a parallel German study shows that ...

... researchers at Heinrich-Heine-University in Düsseldorf, Germany, used adult bone marrow stem cells to regenerate healthy liver tissue, enabling patients to eventually undergo a surgical resection.

A study published in the April issue of the journal Radiology quotes Günther Fürst, M.D., co-author and professor of radiology: “Our study suggests that liver stem cells harvested from the patient’s own bone marrow can further augment and accelerate the liver’s natural capacity to regenerate itself.”

The study involved 13 patients with large central liver malignancies, unable to undergo surgery and compared the use of a portal vein embolization (PVE), a technique currently used to help regenerate liver tissue, with a combination of PVE and an injection of bone marrow stem cells. (LifeSite News)

Again, no mention of, or any admission that, these studies not only show more promise than ESCR, but that they avoid its ethical objections.